Clinical Trials Directory

Trials / Completed

CompletedNCT03260543

Efficacy and Safety of Fermented Ginseng Powder on Liver Function

A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Fermented Ginseng Powder on Liver Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study was conducted to investigate the effects of daily supplementation of fermented ginseng powder on improvement of Liver function.

Detailed description

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of fermented ginseng powder on improvement of Liver function. The investigators measured ALT(Alanine Transaminase) profiles, Liver function index, fatty liver grade, lipid metabolism index, total antioxidant capacity, imflammation index, and Multidimensional Fatigue Scale.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTfermented ginseng powdertablets (2 tablets/day, 125 mg \& 500 mg/day) for 12 weeks.
DIETARY_SUPPLEMENTPlaceboPlacebo for 12 weeks.

Timeline

Start date
2016-07-01
Primary completion
2016-11-01
Completion
2017-08-01
First posted
2017-08-24
Last updated
2018-02-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03260543. Inclusion in this directory is not an endorsement.